| Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. | |
| The McDonald's Drug Pipeline & Your Emails
February 20, 2009 at 10:00 am
|
| Is there a pipeline from the C-suite of McDonald's to the ivory towers of biopharma? At least one "Pharma's Market" reader from overseas thinks so.  Read More |
| Amgen's Epogen & Pedal Pushers
February 19, 2009 at 8:26 am
|
|  The "Amgen Tour of California" is getting a lot more publicity than usual because superstar cyclists Lance Armstrong and Floyd Landis are trying to make comebacks in the race. Read More |
| Eli Lilly Super-Sizes Its Board
February 18, 2009 at 1:39 pm
|
|  Yes, McDonald's has done away with "Super-Size" menu items, but I can still use the American lexicon for, hopefully, an attention-grabbing blog headline. Read More |
| BEAT Beats The Street
February 18, 2009 at 11:08 am
|
|  CardioNet caught my eye and attention when I got a research note from Rick Wise at Leerink Swann about BEAT beating the Street. Read More |
| Stem Cells Sell
February 17, 2009 at 1:45 pm
|
|  Attendance at the 4th Annual Stem Cell Summit is up, by about 50 percent, no less, over last year. All day long privately-held and publicly-traded companies are presenting to around 250 investors. Read More |
| Pfizer, Costco & Glaxo's Ofatumumab
February 13, 2009 at 11:37 am
|
| Friday the 13th. My lucky day for reaching into the Pharma's Market mailbag. Time for your Emails. Read More |
| Pfizer's Ups And Downs
February 12, 2009 at 10:44 am
|
| I thought the dust had pretty much settled on the Pfizer-Wyeth story. Then this morning two analysts coincidentally put out research notes on it. Read More |
| Attention Eli Lilly: Sam's On The Loose
February 11, 2009 at 10:36 am
|
|  I get distracted. I mean, there's a lot to keep track of when you're juggling pharma, biotech and some of the medical device industry. So, thanks to CNBC's bird-dogging assignment desk dude, Jim Forkin, who remembered the significance of February 9th. Read More |
| Roche-Genentech: As The Deal Turns
February 10, 2009 at 9:54 am
|
|  What's $23 between friends, er, sparring business partners? The question brings back memories of my grandfather who was of the generation that would hold a grudge for years against a distant relative who still owed him a small amount of money. Read More |
| For Biotech, Cash Is King
February 9, 2009 at 10:40 am
|
|  I'm at the annual "BIO CEO" conference in Manhattan today. BIO stands for the Biotechnology Industry Organization. It's the industry's main lobbying group and it puts on this meeting to give mostly baby biotechs a moment in the investor spotlight. Read More |
| Hey, Genentech: Now It's Your Turn
February 6, 2009 at 9:53 am
|
|  I've been trying for years to get an interview with Genentech CEO Art Levinson. As far as I know, he's never done a TV chat. Every time I've asked the answer has come back no. I've gotten pretty good access to other execs, but never the top dog. Read More |
| Glaxo's "Papa-Oom-Mow-Mow" Drug
February 5, 2009 at 2:41 pm
|
| I know it's serious business, and in this case, it involves a terrible disease, but this industry cracks me up sometimes. Read More |
| My Big Brother Costco
February 5, 2009 at 11:35 am
|
| Last week, I got two notices that were labeled on the outside as being from Costco and regarding a "Food Safety Recall Notice." They're related to the ongoing peanut (Salmonella) problem. Read More |
| Roche Still Gunning For Genentech
February 4, 2009 at 10:51 am
|
|  Shares of Swiss drugmaker Roche are trading significantly lower overseas and in over-the-counter activity here in the States after the company reported earnings. Read More |
| Progress For Eli Lilly & The FDA
February 3, 2009 at 5:01 pm
|
| Right around the closing bell today an FDA advisory committee voted unanimously in favor of recommending approval of Eli Lilly's bloodthinner called Effient. Read More |
| Merck Lets Its Gardasil Down
February 3, 2009 at 9:55 am
|
|  Before Gardasil came to market two to three years ago, some analystys were saying it would become the biggest-selling vaccine in history. But hope and reality have turned out to be two different things. Read More |
| Amylin In North Dakota? You Betcha
February 2, 2009 at 1:37 pm
|
|  Diabetes drugmaker Amylin Pharmaceuticals is headquartered in San Diego. Like a lot of companies, though, it's incorporated in Delaware. But, if a couple of major shareholders get their way, AMLN could reincorporate in an unlikely state. Read More |
| This email was sent to aslakchristensen.e-news-freemarket@blogger.com .
Don't want to receive this feed any longer? Unsubscribe here. |
| |
Post a Comment